
Yih-horng Shiao
Examiner (ID: 7187, Phone: (571)272-7135 , Office: P/1672 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1672, 1623, 1673, 1691, 1621, 1693 |
| Total Applications | 1088 |
| Issued Applications | 699 |
| Pending Applications | 98 |
| Abandoned Applications | 306 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17805935
[patent_doc_number] => 20220257770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => HYDROPHOBIC HIGHLY BRANCHED CARBOHYDRATE POLYMERS
[patent_app_type] => utility
[patent_app_number] => 17/728121
[patent_app_country] => US
[patent_app_date] => 2022-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14166
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17728121
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/728121 | HYDROPHOBIC HIGHLY BRANCHED CARBOHYDRATE POLYMERS | Apr 24, 2022 | Abandoned |
Array
(
[id] => 19246977
[patent_doc_number] => 20240197961
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => THIOLATED POLYSACCHARIDE DERIVATIVE HYDROGEL, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/286989
[patent_app_country] => US
[patent_app_date] => 2022-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11344
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18286989
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/286989 | THIOLATED POLYSACCHARIDE DERIVATIVE HYDROGEL, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | Apr 18, 2022 | Pending |
Array
(
[id] => 19339475
[patent_doc_number] => 12049656
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-30
[patent_title] => Process for the modification of a glycoprotein using a glycosyltransferase that is or is derived from a b(1,4)-n-acetylgalactosaminyltransferase
[patent_app_type] => utility
[patent_app_number] => 17/711423
[patent_app_country] => US
[patent_app_date] => 2022-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 40809
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 456
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17711423
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/711423 | Process for the modification of a glycoprotein using a glycosyltransferase that is or is derived from a b(1,4)-n-acetylgalactosaminyltransferase | Mar 31, 2022 | Issued |
Array
(
[id] => 19218218
[patent_doc_number] => 20240182922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-06
[patent_title] => VIRAL VECTORS WITH REDUCED IMMUNOGENICITY
[patent_app_type] => utility
[patent_app_number] => 18/283929
[patent_app_country] => US
[patent_app_date] => 2022-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16037
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -51
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18283929
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/283929 | VIRAL VECTORS WITH REDUCED IMMUNOGENICITY | Mar 24, 2022 | Pending |
Array
(
[id] => 18844472
[patent_doc_number] => 20230406876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => ARABINOSE AND PREPARATION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/998902
[patent_app_country] => US
[patent_app_date] => 2022-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8695
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 176
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17998902
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/998902 | Arabinose and preparation and use thereof | Mar 24, 2022 | Issued |
Array
(
[id] => 19279937
[patent_doc_number] => 20240216410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING CANCER THERAPY-INDUCED NEUTROPENIC FEVER AND/OR GVHD
[patent_app_type] => utility
[patent_app_number] => 18/283408
[patent_app_country] => US
[patent_app_date] => 2022-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 65876
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -155
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18283408
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/283408 | METHODS AND COMPOSITIONS FOR TREATING CANCER THERAPY-INDUCED NEUTROPENIC FEVER AND/OR GVHD | Mar 23, 2022 | Pending |
Array
(
[id] => 20040888
[patent_doc_number] => 20250179110
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-05
[patent_title] => IMPROVED OLIGONUCLEOTIDE SYNTHESIS
[patent_app_type] => utility
[patent_app_number] => 18/550793
[patent_app_country] => US
[patent_app_date] => 2022-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27796
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18550793
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/550793 | IMPROVED OLIGONUCLEOTIDE SYNTHESIS | Mar 17, 2022 | Pending |
Array
(
[id] => 17705046
[patent_doc_number] => 20220205052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => BIOMARKERS OF LOW GRADE GLIOMA AND PEDIATRIC NEUROBLASTOMA
[patent_app_type] => utility
[patent_app_number] => 17/697294
[patent_app_country] => US
[patent_app_date] => 2022-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20291
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17697294
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/697294 | Biomarkers of low grade glioma and pediatric neuroblastoma | Mar 16, 2022 | Issued |
Array
(
[id] => 19201447
[patent_doc_number] => 20240173346
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-30
[patent_title] => LINE-1 INHIBITORS TO TREAT CNS AND SYSTEMIC DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/550498
[patent_app_country] => US
[patent_app_date] => 2022-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9602
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18550498
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/550498 | LINE-1 INHIBITORS TO TREAT CNS AND SYSTEMIC DISEASES | Mar 14, 2022 | Pending |
Array
(
[id] => 17761478
[patent_doc_number] => 20220235090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => OLIGONUCLEOTIDE MANUFACTURING METHOD
[patent_app_type] => utility
[patent_app_number] => 17/654700
[patent_app_country] => US
[patent_app_date] => 2022-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26899
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 220
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17654700
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/654700 | Oligonucleotide manufacturing method | Mar 13, 2022 | Issued |
Array
(
[id] => 19156057
[patent_doc_number] => 20240148764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => INHIBITORS OF SGLT-1 AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/280293
[patent_app_country] => US
[patent_app_date] => 2022-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10372
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18280293
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/280293 | INHIBITORS OF SGLT-1 AND USES THEREOF | Mar 3, 2022 | Pending |
Array
(
[id] => 19296435
[patent_doc_number] => 20240224998
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2024-07-11
[patent_title] => AGRICULTURAL COMPOSITION COMPRISING KASUGAMYCIN
[patent_app_type] => utility
[patent_app_number] => 18/548122
[patent_app_country] => US
[patent_app_date] => 2022-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8912
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18548122
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/548122 | AGRICULTURAL COMPOSITION COMPRISING KASUGAMYCIN | Feb 27, 2022 | Pending |
Array
(
[id] => 19296435
[patent_doc_number] => 20240224998
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2024-07-11
[patent_title] => AGRICULTURAL COMPOSITION COMPRISING KASUGAMYCIN
[patent_app_type] => utility
[patent_app_number] => 18/548122
[patent_app_country] => US
[patent_app_date] => 2022-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8912
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18548122
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/548122 | AGRICULTURAL COMPOSITION COMPRISING KASUGAMYCIN | Feb 27, 2022 | Pending |
Array
(
[id] => 19491651
[patent_doc_number] => 12110347
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-08
[patent_title] => Enzymatic synthesis of soluble glucan fiber
[patent_app_type] => utility
[patent_app_number] => 17/680581
[patent_app_country] => US
[patent_app_date] => 2022-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41326
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17680581
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/680581 | Enzymatic synthesis of soluble glucan fiber | Feb 24, 2022 | Issued |
Array
(
[id] => 19535562
[patent_doc_number] => 12128095
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-29
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 17/672126
[patent_app_country] => US
[patent_app_date] => 2022-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 50
[patent_no_of_words] => 57572
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 434
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17672126
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/672126 | None | Feb 14, 2022 | Issued |
Array
(
[id] => 17867387
[patent_doc_number] => 20220290123
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => METHOD FOR PURIFYING RNA
[patent_app_type] => utility
[patent_app_number] => 17/668322
[patent_app_country] => US
[patent_app_date] => 2022-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12970
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17668322
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/668322 | METHOD FOR PURIFYING RNA | Feb 8, 2022 | Abandoned |
Array
(
[id] => 17790580
[patent_doc_number] => 20220249671
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => CARBOHYDRATE COMPOSITION AS PHARMACEUTICAL INGREDIENT AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/666529
[patent_app_country] => US
[patent_app_date] => 2022-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10495
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17666529
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/666529 | Carbohydrate composition as pharmaceutical ingredient and use thereof | Feb 6, 2022 | Issued |
Array
(
[id] => 18075797
[patent_doc_number] => 20220401409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF MUSCULAR DISORDERS AND BONE DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/665116
[patent_app_country] => US
[patent_app_date] => 2022-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14663
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17665116
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/665116 | COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF MUSCULAR DISORDERS AND BONE DISORDERS | Feb 3, 2022 | Abandoned |
Array
(
[id] => 19001891
[patent_doc_number] => 20240065962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-29
[patent_title] => COSMETIC PREPARATION
[patent_app_type] => utility
[patent_app_number] => 18/271521
[patent_app_country] => US
[patent_app_date] => 2022-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10665
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18271521
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/271521 | COSMETIC PREPARATION | Jan 27, 2022 | Pending |
Array
(
[id] => 17593482
[patent_doc_number] => 20220143055
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => NICOTINAMIDE RIBOSIDE AND PTEROSTILBENE COMPOSITIONS AND METHODS FOR TREATMENT OF NEURODEGENERATIVE DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/580999
[patent_app_country] => US
[patent_app_date] => 2022-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13744
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17580999
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/580999 | Nicotinamide riboside and pterostilbene compositions and methods for treatment of neurodegenerative disorders | Jan 20, 2022 | Issued |